Table 3.
Patient demographics and characteristics at baseline
| All patients N=1485 |
Diabetes specialist n=617 | Non-specialist n=868 | |
| Age (years), mean (SD) | 59.7 (13.3) | 55.6 (12.8) | 62.7 (12.8) |
| Female, n (%) | 567 (38.2) | 226 (36.6) | 341 (39.3) |
| BMI (kg/m2), median (IQR) | 25.5 (23.0‒28.6) | 25.6 (23.0‒28.8) | 25.4 (23.0‒28.6) |
| ≥25, n (%) | 813 (54.7) | 345 (55.9) | 468 (53.9) |
| Disease duration (years), mean (SD) | 0.9 (1.9) | 0.8 (1.8) | 0.9 (1.9) |
| Baseline HbA1c (%), mean (SD) | 8.1 (1.9) | 8.4 (1.9) | 7.9 (1.8) |
| Target HbA1c (%), mean (SD) | 6.5 (0.5) | 6.7 (0.6) | 6.4 (0.4) |
| Classification in CKD stage by eGFR, n (%), n=1250* | |||
| G1 | 369 (29.5) | 199 (39.3) | 170 (22.8) |
| G2 | 687 (55.0) | 255 (50.4) | 432 (58.1) |
| G3a | 143 (11.4) | 46 (9.1) | 97 (13.0) |
| G3b | 36 (2.9) | 5 (1.0) | 31 (4.2) |
| G4 | 11 (0.9) | 1 (0.2) | 10 (1.3) |
| G5 | 4 (0.3) | 0 (0.0) | 4 (0.5) |
| Diabetic complications, n (%) | 196 (13.2) | 123 (19.9) | 73 (8.4) |
| Cardiovascular disease, n (%) | 91 (6.1) | 14 (2.3) | 77 (8.9) |
| Dyslipidemia, n (%) | 856 (57.6) | 300 (48.6) | 556 (64.1) |
| Hypertension, n (%) | 760 (51.2) | 234 (37.9) | 526 (60.6) |
*Number of patients with available eGFR data.
BMI, body mass index; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin.